While chloride ligands are typically quickly exchanged under physiological conditions, bromo and in particular iodo ligands are relatively inert to hydrolysis 30,31
And we're talking here about compounded pharmacies primarily, but there are a bunch of companies that are involved in this and other, you know, telehealth companies that are getting in on this market or at least trying to
GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic peptide agonists have several mechanisms of action, including reduction of gastric emptying, inhibition of glucagon secretion, beneficial changes in the intestinal microbiome, and direct effects on hypothalamic nuclei to enhance satiety (which promotes weight loss)
Curious on what you think: is there appetite for psychiatry-specific prescribing or co-management guidance, or are we going to keep improvising while the endocrinologists and primary care write the rules
Weight reduction achieved through GLP-1 agonists can lead to hormonal adjustments that influence sexual function
